Wave Life Sciences (WVE) Change in Acquisitions & Divestments (2022)
Wave Life Sciences (WVE) posted Change in Acquisitions & Divestments of $25.0 million for Q4 2022, little changed on a QoQ basis from $25.0 million in Q3 2022.
Wave Life Sciences (WVE) Change in Acquisitions & Divestments (2022) Analysis & Trends
Wave Life Sciences' Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $25.0 million for Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Wave Life Sciences | 1.20 Bn | 651.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 25.04 Mn |
| Dec 31, 2022 | 25.04 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Sep 30, 2022 | 25.00 Mn |